Cargando…

Impact of BSE on the biotechnology industry — detection and risk assessment

This feature briefly looks at filtration technologies that are being developed by Pall Corp to reduce the potential risk of ‘Mad Cow Disease’ in biological products and drugs. It also provides details of proprietary technology that is designed to reduce prions from blood prior to a transfusion.

Detalles Bibliográficos
Autor principal: Atkinson, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148827/
http://dx.doi.org/10.1016/S0958-2118(04)00238-1
Descripción
Sumario:This feature briefly looks at filtration technologies that are being developed by Pall Corp to reduce the potential risk of ‘Mad Cow Disease’ in biological products and drugs. It also provides details of proprietary technology that is designed to reduce prions from blood prior to a transfusion.